Articles

In a study of more than 4,000 black women in Los Angeles, those who lived in areas with higher levels of traffic-related air pollution were at increased risk of diabetes and hypertension….

In a once weekly injection of exenatide for Drug-Naive Patients with Type 2 Diabetes (DURATION-4) in a 26-week double-blind study they found that exenatide once weekly (EQW) was noninferior to metformin (MET) but not pioglitazone (PIO) and superior to sitagliptin (SITA) with regard to HbA1c reduction at 26 weeks….

Vivus Inc said the FDA has asked the company to remove a contraindication in the proposed label of its obesity drug Qnexa, a move that could help it reach a broader patient population.…

The study findings indicate that medical professionals with normal BMI more frequently reported discussing weight loss with patients than overweight or obese medical professionals….

Two new studies from a team of investigators suggest two possible predictors for the development of metabolic syndrome in children prescribed second-generation antipsychotics (SGAs)….

The study investigated the comparative costs of two different insulin regimens in type 2 diabetes based on data from the GINGER study, which investigated the efficacy and safety of an intensified insulin regimen.…

Our own killer T-cells in the human body which help protect us from disease may inadvertently destroy cells that produce insulin.…

Diabetes patients who receive regularly scheduled monthly care to learn how to improve their health have a more rapid recovery compared with similar patients who receive only sporadic healthcare visits.…

A highly sensitive troponin test revealed evidence of subclinical heart damage in patients with hyperglycemia but no known coronary artery disease or heart failure, with particularly high enzyme levels in those with diabetes….

An immune regulator from healthy cord blood stem cells (CB-SCs) can “educate” the T cells of a person with type 1 diabetes, enabling the pancreas to produce insulin.…